Close
Apco Worldwide loader

Recommendations for Harmonizing Health and Sustainability: Analyzing the Intersection of EU Environmental Regulations and Pharmaceutical Legislation

As sustainability is gaining momentum and has become one of the top policy priorities across the world, pharmaceutical industry is under increasing pressure to contribute to achieving environmental objectives...
Read More

Changes Loom for CMS and Drug Manufacturers

As drug manufacturers grapple with the shift away from established methods of government drug payments, several questions remain: how well will CMS be able to execute this new law?  What impact will it have on the industry? Will it actually lower prices for seniors?..
Read More

Unraveling Health Inequalities: Understanding, Measuring and Taking Action 

Health inequalities, which are systematic disparities in the health status and experiences of different population groups based on social determinants, have gained significant attention within the public health domain in recent years. This focus has been amplified by the global impact of the COVID-19 pandemic and the momentum of the racial justice movement...
Read More

Keeping Pace: UK Tech Regulation in the Modern Age of Health

As medical device regulation begins to impact companies that sit outside of the traditional health care setting, now is the time to act and ensure they are prepared for forthcoming regulatory changes and equipped to influence them...
Read More

ESG Pulse of Pharmaceutical Companies in Highly Regulated Markets

How are pharmaceutical companies performing on ESG priorities without “green hushing?”..
Read More

Both Prevention and Adaptation Are Vital to Antimicrobial Resistance

The UK’s response to antimicrobial resistance could be likened to efforts to improve our resilience to climate change. Both should not be considered a substitute for the preventative actions of reducing carbon emissions and reducing misuse of antibiotics...
Read More

Europe’s Pharmaceutical Framework has Been Reopened

Two decades after the first Medicinal Products Regulation and Directive was adopted, the EU is re-opening a pandora’s box of legislation in response to long-standing concerns that the current European pharmaceutical framework does not go far enough to address unmet medical needs, inequities in access to approved therapies and the burden of rising costs on national health care budgets...
Read More

Lessons Learned From the World Health Summit 2022

APCO’s Germany team was on the ground in Berlin to cover the latest developments on the global health agenda...
Read More

Why Respiratory Health Is at the Core of Climate Change

Climate change leads to prolonged heat waves, increased length and severity of the pollen season and more which put human health at risk...
Read More

Health Care Disruption Is Here: A Few Considerations for Disruptors

We are in a constant whirlwind of industry updates that fundamentally change the way health care is delivered...
Read More
Close